Target intelligence / Profile preview

Immunoglobulin kappa variable 2-10 (IGKV2-10)

Target: IGKV2-10
Molecular classification: Pseudogene, Immunoglobulin superfamily

Overview

Immunoglobulin kappa variable 2-10 (IGKV2-10) is classified as a pseudogene in the locus encoding the variable domain of the kappa light chain in immunoglobulins (antibodies). Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements; thus, IGKV2-10 does not encode a protein product and is not involved in typical antibody antigen recognition or immune signaling. There is no evidence that this pseudogene has any known direct functional or therapeutic relevance, nor is it considered a drug target.

Other names: IGKV2-10IGKV210L7

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2-10 (IGKV2-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2-10 (IGKV2-10).

Explore the full profile